Industries de la santé
07 Avril 2014
The BMJ and Cochrane call on government and health policy decision makers to review guidance on use of Tamiflu in light of most recent evidence |Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. This is according to the updated Cochrane...
Plus d'articles...
- Monitoring Inactive Hepatitis B Patients is Cost-Effective Strategy for Shanghai
- Reconnaissance scientifique internationale de l’efficacité thérapeutique du dispositif médical Cefaly®, une innovation technologique mise au point par la firme liégeoise Cefaly Technology dans le traitement de la migraine
- Researchers propose alternative way to allocate science funding
- Bone Therapeutics and partners awarded highly competitive €3.8 million Marie Curie research grant